Literature DB >> 971416

Transfer of heme from heme-albumin to hemopexin.

W T Morgan, H H Liem, R P Sutor, U Muller-Ebergard.   

Abstract

Exchange of heme in vitro between two heme-binding serum proteins, albumin and hemopexin, was examined spectrophotometrically. Hemopexin, albumin and heme in molar ratios of 1 : 70 : 1 were incubated at 22 degrees C, pH 7.3. The heme was added as free heme, heme-hemopexin or methemalbumin. Due to the high affinity of hemopexin for heme, Kd near 10(-13) M, only negligible amounts of heme were transferred from hemopexin to albumin in 48 h. However, more than 80% of heme was transferred from methemalbumin to hemopexin within 24 h. Heme added to a 1 : 70 mixture of the apo-proteins is initially bound by albumin; but more than 90% is bound by hemopexin in 24 h. Addition of dithionite causes nearly all of the heme present, whether added as free heme or methemalbumin, to associate with hemopexin in 15 min. Albumin thus appears to have a much lower affinity for ferro- than for ferri-heme. Results obtained from similar experiments with human serum and human serum made hemopexin-free by immunoadsorption fully corroborate those obtained with mixtures of purified albumin and hemopexin. These observations suggest that the rate-limiting step in the heme transport function of hemopexin is the formation of the heme-hemopexin complex, rather than the uptake of the complex by the liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971416     DOI: 10.1016/0304-4165(76)90387-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  Sequestration and scavenging of iron in infection.

Authors:  Nermi L Parrow; Robert E Fleming; Michael F Minnick
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  Intracellular distribution of haem after uptake by different receptors. Haem-haemopexin and haem-asialo-haemopexin.

Authors:  A Smith
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

4.  Hemopexin decreases hemin accumulation and catabolism by neural cells.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Neurochem Int       Date:  2012-02-07       Impact factor: 3.921

5.  ApoHRP-based assay to measure intracellular regulatory heme.

Authors:  Hani Atamna; Marmik Brahmbhatt; Wafa Atamna; Gregory A Shanower; Joseph M Dhahbi
Journal:  Metallomics       Date:  2015-02       Impact factor: 4.526

6.  Regulation of intracellular heme trafficking revealed by subcellular reporters.

Authors:  Xiaojing Yuan; Nicole Rietzschel; Hanna Kwon; Ana Beatriz Walter Nuno; David A Hanna; John D Phillips; Emma L Raven; Amit R Reddi; Iqbal Hamza
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

7.  Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein.

Authors:  A Smith; W T Morgan
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

8.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

9.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

10.  Significant role of an exocellular protease in utilization of heme by Vibrio vulnificus.

Authors:  Y Nishina; S Miyoshi; A Nagase; S Shinoda
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.